Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alfred G. Hildebrandt, Dieter Schwarz, Solveigh Krusekopf, Ullrich Kleeberg & Ivar Roots. (2007) Recalling P446. P4501A1 (CYP1A1) Opting for Clinical Application. Drug Metabolism Reviews 39:2-3, pages 323-341.
Read now
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
Read now
Marc Vermeir, Pieter Annaert, Rao NVS Mamidi, Dirk Roymans, Willem Meuldermans & Geert Mannens. (2005) Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 75-90.
Read now
Read now
Articles from other publishers (35)
Hyunki Cho, Ian Choi, Sang Kyum Kim, Seungyun Baik & Chang Seon Ryu. (2022) LC-MS-based assay of granisetron 7-hydroxylation activity for the evaluation of CYP1A1 induction from diesel particulate matter-exposed hepatic and respiratory cell lines. Food and Chemical Toxicology 161, pages 112829.
Crossref
Crossref
Toshitaka Miura, Ryo Onodera, Jun Terashima, Shogo Ozawa & Wataru Habano. (2021)
β‑naphthoflavone‑induced upregulation of
CYP1B1
expression is mediated by the preferential binding of aryl hydrocarbon receptor to unmethylated xenobiotic responsive elements
. Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Dustyn A. Barnette, Mary A. Schleiff, Arghya Datta, Noah Flynn, S. Joshua Swamidass & Grover P. Miller. (2021) Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam. Toxicology Letters 338, pages 10-20.
Crossref
Crossref
Alan L. Myers, Jitesh D. Kawedia, Ahmed Nader, Jason R. Westin & Brandon R. Shank. (2019) A rare case of methotrexate and primaquine co‐administration in a mantle cell lymphoma patient. Journal of Clinical Pharmacy and Therapeutics 44:5, pages 800-804.
Crossref
Crossref
Y. Kapelyukh, C. J. Henderson, N. Scheer, A. Rode & C. R. Wolf. (2019) Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice. Drug Metabolism and Disposition 47:8, pages 907-918.
Crossref
Crossref
Yinting Chen, Linjuan Zeng, Yong Wang, William H. Tolleson, Bridgett Knox, Si Chen, Zhen Ren, Lei Guo, Nan Mei, Feng Qian, Kaihong Huang, David Liu, Weida Tong, Dianke Yu & Baitang Ning. (2017) The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p. Biochemical Pharmacology 145, pages 178-191.
Crossref
Crossref
Sabrina E. Gambaro, Maria C. Robert, Claudio Tiribelli & Silvia Gazzin. (2014) Role of brain cytochrome P450 mono-oxygenases in bilirubin oxidation-specific induction and activity. Archives of Toxicology 90:2, pages 279-290.
Crossref
Crossref
Aneta Novotna, Alzbeta Srovnalova, Michaela Svecarova, Martina Korhonova, Iveta Bartonkova & Zdenek Dvorak. (2014) Differential Effects of Omeprazole and Lansoprazole Enantiomers on Aryl Hydrocarbon Receptor in Human Hepatocytes and Cell Lines. PLoS ONE 9:6, pages e98711.
Crossref
Crossref
Toru Arai, Yoshikazu Inoue, Yumiko Sasaki, Kazunobu Tachibana, Keiko Nakao, Chikatoshi Sugimoto, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi & Seiji Hayashi. (2014) Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis. Respiratory Investigation 52:2, pages 136-143.
Crossref
Crossref
Kikuko Araki, Keisuke Watanabe, Yasushi Yamazoe & Kouichi Yoshinari. (2012) Liver X receptor α bidirectionally transactivates human CYP1A1 and CYP1A2 through two cis-elements common to both genes. Toxicology Letters 215:1, pages 16-24.
Crossref
Crossref
George C. Mayne, David I. Watson & Damian J. Hussey. (2012) COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor. ANZ Journal of Surgery 82:10, pages 691-696.
Crossref
Crossref
Alexander V. LyubimovJiunn H. Lin & Jianjun Guo. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
21
.
Takeshi Kajiwara, Takahiro Konishi & Mitsuhisa Yamano. (2012) Asymmetric catalytic hydrogenation for large scale preparation of optically active 2-(N-benzoylamino)cyclohexanecarboxylic acid derivatives. Catalysis Science & Technology 2:10, pages 2146.
Crossref
Crossref
M Dobrinas, J Cornuz, B Oneda, M Kohler Serra, M Puhl & C B Eap. (2011) Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility. Clinical Pharmacology & Therapeutics 90:1, pages 117-125.
Crossref
Crossref
Jere Lindén, Sanna Lensu, Jouko Tuomisto & Raimo Pohjanvirta. (2010) Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. Frontiers in Neuroendocrinology 31:4, pages 452-478.
Crossref
Crossref
Kazuaki Matsuoka-Kawano, Kouichi Yoshinari, Sekio Nagayama & Yasushi Yamazoe. (2010) TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes. Chemico-Biological Interactions 185:1, pages 33-41.
Crossref
Crossref
Shobana Ganesan, Babu L. Tekwani, Rajnish Sahu, Lalit M. Tripathi & Larry A. Walker. (2009) Cytochrome P450-dependent toxic effects of primaquine on human erythrocytes. Toxicology and Applied Pharmacology 241:1, pages 14-22.
Crossref
Crossref
Ganesh RajaramanGuixiang YangJie ChenThomas K.H. Chang. (2009)
Modulation of
CYP1B1
and
CYP1A1
gene expression and activation of aryl hydrocarbon receptor by
Ginkgo biloba
extract in MCF-10A human mammary epithelial cells
. Canadian Journal of Physiology and Pharmacology 87:9, pages 674-683.
Crossref
Crossref
E. Horváthová, D. Slameňová, L. Maršálková, M. Šramková & L. Wsólová. (2009) Effects of borneol on the level of DNA damage induced in primary rat hepatocytes and testicular cells by hydrogen peroxide. Food and Chemical Toxicology 47:6, pages 1318-1323.
Crossref
Crossref
Kouichi Yoshinari, Rika Ueda, Kazutomi Kusano, Tsutomu Yoshimura, Kiyoshi Nagata & Yasushi Yamazoe. (2008) Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochemical Pharmacology 76:1, pages 139-145.
Crossref
Crossref
E. J. Buenz. (2007) A high-throughput cell-based toxicity analysis of drug metabolites using flow cytometry. Cell Biology and Toxicology 23:5, pages 361-365.
Crossref
Crossref
Makoto Kosuge, Hiroko Takizawa, Haruka Maehashi, Tomokazu Matsuura & Senya Matsufuji. (2007) A comprehensive gene expression analysis of human hepatocellular carcinoma cell lines as components of a bioartificial liver using a radial flow bioreactor. Liver International 27:1.
Crossref
Crossref
Jiunn H. Lin. (2006) CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications. Pharmaceutical Research 23:6, pages 1089-1116.
Crossref
Crossref
Henning Blume, Frank Donath, Andr?? Warnke & Barbara S Schug. (2006) Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors. Drug Safety 29:9, pages 769-784.
Crossref
Crossref
Darina Slameňová, Eva Horváthová & Miriam Bartková. (2006) Nature of DNA lesions induced in human hepatoma cells, human colonic cells and human embryonic lung fibroblasts by the antiretroviral drug 3′-azido-3′-deoxythymidine. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 593:1-2, pages 97-107.
Crossref
Crossref
Solveigh Krusekopf & Ivar Roots. (2005) St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways. Pharmacogenetics and Genomics 15:11, pages 817-829.
Crossref
Crossref
Kristin G. Nørsett, Astrid Lægreid, Mette Langaas, Sara Wörlund, Reidar Fossmark, Helge L. Waldum & Arne K. Sandvik. (2005) Molecular characterization of rat gastric mucosal response to potent acid inhibition. Physiological Genomics 22:1, pages 24-32.
Crossref
Crossref
Ralph Menzel, Matthias Rödel, Jana Kulas & Christian E.W. Steinberg. (2005) CYP35: Xenobiotically induced gene expression in the nematode Caenorhabditis elegans. Archives of Biochemistry and Biophysics 438:1, pages 93-102.
Crossref
Crossref
Xiaochao Ma, Jeffrey R. Idle, Kristopher W. Krausz & Frank J. Gonzalez. (2005) METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450. Drug Metabolism and Disposition 33:4, pages 489-494.
Crossref
Crossref
Anna Phillips, Steve R. Hood, G. Gordon Gibson & Nick J. Plant. (2005) IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION. Drug Metabolism and Disposition 33:2, pages 233-242.
Crossref
Crossref
I. SchaeffnerJ. PettersH. AurichP. FrohbergB. Christ. (2005) A Microtiterplate-Based Screening Assay to Assess Diverse Effects on Cytochrome P450 Enzyme Activities in Primary Rat Hepatocytes by Various Compounds. ASSAY and Drug Development Technologies 3:1, pages 27-38.
Crossref
Crossref
Darina Slamenova, Irena Masterova, Juraj Labaj, Eva Horvathova, Pavol Kubala, Jana Jakubikova & Ladislava Wsolova. (2004) Cytotoxic and DNA-Damaging Effects of Diterpenoid Quinones from the Roots of Salvia officinalis L. on Colonic and Hepatic Human Cells Cultured in vitro. Pharmacology and Toxicology 94:6, pages 282-290.
Crossref
Crossref
J Velı́k, V Baliharová, J Fink-Gremmels, S Bull, J Lamka & L Skálová. (2004) Benzimidazole drugs and modulation of biotransformation enzymes. Research in Veterinary Science 76:2, pages 95-108.
Crossref
Crossref
Nick Plant. (2004) Strategies for using in vitro screens in drug metabolism. Drug Discovery Today 9:7, pages 328-336.
Crossref
Crossref
Solveigh Krusekopf, Ivar Roots & Ullrich Kleeberg. (2003) Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. European Journal of Pharmacology 466:1-2, pages 7-12.
Crossref
Crossref